20-nm-sized mesoporous silica nanoparticles with porphyrin photosensitizers for in vitro photodynamic therapy
Source abstract
Abstract
We report the synthesis of 20-nm-sized mesoporous silica nanoparticles encapsulating three different porphyrin photosensitizers (PS). Synthesized by the sol–gel method, in the presence of cetyltrimethylammonium bromide surfactant and tetraorthosilicate as silica source, we developed those nanoparticles with the aim of treating cancer cells using photodynamic therapy. The colloidal stability, due to the PEG-silane chain grafted on the surface, was demonstrated at 37 C in cell culture medium. Then, nanoparticles were functionalized by silylated squarate mannose and used in MCF-7 breast cancer cells for one-photon therapy. Promising results were obtained after 5 h of incubation.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Knezevic NZ, Durand J-O (2015) Large pore mesoporous silica nanomaterials for application in delivery of biomolecules. Nanoscale 7(6):2199–2209. doi: 10.1039/c4nr06114d10.1039/c4nr06114d ↗
2. Knezevic NZ, Durand J-O (2015) Targeted treatment of cancer with nanotherapeutics based on mesoporous silica nanoparticles. ChemPlusChem 80(1):26–36. doi: 10.1002/cplu.20140236910.1002/cplu.201402369 ↗
3. Zhang Y, Yan J, Liu S (2014) Biocompatibility and biomedical applications of functionalized mesoporous silica nanoparticles. Biointerface Res Appl Chem 4 (3):767–775, 769
4. Yang K-N, Zhang C-Q, Wang W, Wang PC, Zhou J-P, Liang X-J (2014) pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment. Cancer Biol Med 11(1):34–43
5. Nadrah P, Planinsek O, Gaberscek M (2014) Stimulus-responsive mesoporous silica particles. J Mater Sci 49(2):481–49510.1007/s10853-013-7726-6 ↗
6. He Q, Shi J (2014) MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition. Adv Mater 26(3):391–41110.1002/adma.201303123 ↗
7. Dave PN, Chopda LV (2014) A review on application of multifunctional mesoporous nanoparticles in controlled release of drug delivery. Mater Sci Forum 781 (Multi-functional nanomaterials and their emerging applications):17–24, 19 pp10.4028/www.scientific.net/MSF.781.17 ↗
8. Argyo C, Weiss V, Braeuchle C, Bein T (2014) Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem Mater 26(1):435–45110.1021/cm402592t ↗
9. Mai WX, Meng H (2013) Mesoporous silica nanoparticles: a multifunctional nano therapeutic system. Integr Biol 5(1):19–28. doi: 10.1039/c2ib20137b10.1039/c2ib20137b ↗
10. Mody KT, Popat A, Mahony D, Cavallaro AS, Yu C, Mitter N (2013) Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery. Nanoscale 5(12):5167–517910.1039/c3nr00357d ↗
11. Mamaeva V, Sahlgren C, Linden M (2013) Mesoporous silica nanoparticles in medicine-Recent advances. Adv Drug Deliv Rev 65(5):689–702. doi: 10.1016/j.addr.2012.07.01810.1016/j.addr.2012.07.018 ↗
12. Duan R, Xia F, Jiang L (2013) Constructing tunable nanopores and their application in drug delivery. ACS Nano 7(10):8344–834910.1021/nn405092w ↗
13. Douroumis D, Onyesom I, Maniruzzaman M, Mitchell J (2013) Mesoporous silica nanoparticles in nanotechnology. Crit Rev Biotechnol 33(3):229–24510.3109/07388551.2012.685860 ↗
14. Chen Y, Chen H, Shi J (2013) In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles. Adv Mater 25(23):3144–3176. doi: 10.1002/adma.20120529210.1002/adma.201205292 ↗
15. Yang P, Gai S, Lin J (2012) Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 41(9):3679–3698. doi: 10.1039/c2cs15308d10.1039/c2cs15308d ↗
16. Vivero-Escoto JL, Huxford-Phillips RC, Lin WB (2012) Silica-based nanoprobes for biomedical imaging and theranostic applications. Chem Soc Rev 41(7):2673–2685. doi: 10.1039/c2cs15229k10.1039/c2cs15229k ↗
17. Tang F, Li L, Chen D (2012) Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater 24(12):1504–1534. doi: 10.1002/adma.20110476310.1002/adma.201104763 ↗
18. Lin Y-S, Hurley KR, Haynes CL (2012) Critical considerations in the biomedical use of mesoporous silica nanoparticles. J Phys Chem Lett 3(3):364–37410.1021/jz2013837 ↗
19. Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JI (2012) Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev 41(7):2590–2605. doi: 10.1039/c1cs15246g10.1039/c1cs15246g ↗
20. Asefa T, Tao Z (2012) Biocompatibility of mesoporous silica nanoparticles. Chem Res Toxicol 25(11):2265–2284. doi: 10.1021/tx300166u10.1021/tx300166u ↗
21. Yang Y-W (2011) Towards biocompatible nanovalves based on mesoporous silica nanoparticles. Medchemcomm 2(11):1033–1049. doi: 10.1039/c1md00158b10.1039/c1md00158b ↗
22. Popat A, Hartono SB, Stahr F, Liu J, Qiao SZ, Lu GQ (2011) Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers. Nanoscale 3(7):2801–2818. doi: 10.1039/c1nr10224a10.1039/c1nr10224a ↗
23. He Q, Shi J (2011) Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem 21(16):5845–585510.1039/c0jm03851b ↗
24. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY (2010) Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6(18):1952–196710.1002/smll.200901789 ↗
25. Coti KK, Belowich ME, Liong M, Ambrogio MW, Lau YA, Khatib HA, Zink JI, Khashab NM, Stoddart JF (2009) Mechanised nanoparticles for drug delivery. Nanoscale 1(1):16–3910.1039/b9nr00162j ↗
26. Slowing II, Vivero-Escoto JL, Wu C-W, Lin VSY (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60(11):1278–128810.1016/j.addr.2008.03.012 ↗
27. Trewyn BG, Slowing II, Giri S, Chen H-T, Lin VSY (2007) Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc Chem Res 40(9):846–85310.1021/ar600032u ↗
28. Trewyn BG, Giri S, Slowing II, Lin VSY (2007) Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem Commun 31:3236–324510.1039/b701744h ↗
29. Slowing II, Trewyn BG, Giri S, Lin VSY (2007) Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater 17(8):1225–123610.1002/adfm.200601191 ↗
30. Wu S-H, Mou C-Y, Lin H-P (2013) Synthesis of mesoporous silica nanoparticles. Chem Soc Rev 42(9):3862–3875. doi: 10.1039/c3cs35405a10.1039/c3cs35405a ↗
31. Slowing II, Vivero-Escoto JL, Trewyn BG, Lin VSY (2010) Mesoporous silica nanoparticles: structural design and applications. J Mater Chem 20(37):7924–793710.1039/c0jm00554a ↗
32. Hoshikawa Y, Yabe H, Nomura A, Yamaki T, Shimojima A, Okubo T (2010) Mesoporous silica nanoparticles with remarkable stability and dispersibility for antireflective coatings. Chem Mater 22(1):12–14. doi: 10.1021/cm902239a10.1021/cm902239a ↗
33. Huh S, Chen H-T, Wiench JW, Pruski M, Lin VSY (2005) Cooperative catalysis by general acid and base bifunctionalized mesoporous silica nanospheres. Angew Chem Int Ed Engl 44(12):1826–183010.1002/anie.200462424 ↗
34. Lei J, Wang L, Zhang J (2010) Ratiometric pH sensor based on mesoporous silica nanoparticles and Foerster resonance energy transfer. Chem Commun (Cambridge, UK) 46(44):8445–844710.1039/c0cc03310c ↗
35. Mondragon L, Mas N, Ferragud V, de la Torre C, Agostini A, Martinez-Manez R, Sancenon F, Amoros P, Perez-Paya E, Orzaez M (2014) Enzyme- responsive intracellular- controlled release using silica mesoporous nanoparticles capped with e- poly- l- lysine. Chem Eur J 20(18):5271–5281. doi: 10.1002/chem.20140014810.1002/chem.201400148 ↗
36. Chouikrat R, Seve A, Vanderesse R, Benachour H, Barberi-Heyob M, Richeter S, Raehm L, Durand JO, Verelst M, Frochot C (2012) Non polymeric nanoparticles for photodynamic therapy applications: recent developments. Curr Med Chem 19(6):781–79210.2174/092986712799034897 ↗
37. Couleaud P, Morosini V, Frochot C, Richeter S, Raehm L, Durand JO (2010) Silica-based nanoparticles for photodynamic therapy applications. Nanoscale 2(7):1083–1095. doi: 10.1039/c0nr00096e10.1039/c0nr00096e ↗
38. Yamamoto E, Kitahara M, Tsumura T, Kuroda K (2014) Preparation of size-controlled monodisperse colloidal mesoporous silica nanoparticles and fabrication of colloidal crystals. Chem Mater 26(9):2927–2933. doi: 10.1021/cm500619p10.1021/cm500619p ↗
39. Pan L, Liu J, He Q, Wang L, Shi J (2013) Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. Biomaterials 34(11):2719–2730. doi: 10.1016/j.biomaterials.2012.12.04010.1016/j.biomaterials.2012.12.040 ↗
40. Yi Z, Dumee LF, Garvey CJ, Feng C, She F, Rookes JE, Mudie S, Cahill DM, Kong L (2015) A new insight into growth mechanism and kinetics of mesoporous silica nanoparticles by in situ small angle X-ray scattering. Langmuir 31(30):8478–8487. doi: 10.1021/acs.langmuir.5b0163710.1021/acs.langmuir.5b01637 ↗
41. Urata C, Aoyama Y, Tonegawa A, Yamauchi Y, Kuroda K (2009) Dialysis process for the removal of surfactants to form colloidal mesoporous silica nanoparticles. Chem Commun 34:5094–5096. doi: 10.1039/b908625k10.1039/b908625k ↗
42. Qiao Z-A, Zhang L, Guo M, Liu Y, Huo Q (2009) Synthesis of mesoporous silica nanoparticles via controlled hydrolysis and condensation of silicon alkoxide. Chem Mater 21(16):3823–3829. doi: 10.1021/cm901335k10.1021/cm901335k ↗
43. Lu F, Wu SH, Hung Y, Mou CY (2009) Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5(12):1408–1413. doi: 10.1002/smll.20090000510.1002/smll.200900005 ↗
44. Ma K, Werner-Zwanziger U, Zwanziger J, Wiesner U (2013) Controlling growth of ultrasmall sub-10 nm fluorescent mesoporous silica nanoparticles. Chem Mater 25(5):677–691. doi: 10.1021/cm303242h10.1021/cm303242h ↗
45. Ma K, Sai H, Wiesner U (2012) Ultrasmall sub-10 nm near-infrared fluorescent mesoporous silica nanoparticles. J Am Chem Soc 134(32):13180–13183. doi: 10.1021/ja304978310.1021/ja3049783 ↗
46. Wu M, Meng Q, Chen Y, Du Y, Zhang L, Li Y, Zhang L, Shi J (2015) Large-pore ultrasmall mesoporous organosilica nanoparticles: micelle/precursor co-templating assembly and nuclear-targeted gene delivery. Adv Mater (Weinheim, Ger) 27(2):215–222. doi: 10.1002/adma.20140425610.1002/adma.201404256 ↗
47. Pan L, Liu J, He Q, Shi J (2014) MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression. Adv Mater (Weinheim, Ger) 26(39):6742–6748. doi: 10.1002/adma.20140275210.1002/adma.201402752 ↗
48. Li Z-Y, Liu Y, Hu J-J, Xu Q, Liu L-H, Jia H-Z, Chen W-H, Lei Q, Rong L, Zhang X-Z (2014) Stepwise-acid-active multifunctional mesoporous silica nanoparticles for tumor-specific nucleus-targeted drug delivery. ACS Appl Mater Interfaces 6(16):14568–1457510.1021/am503846p ↗
49. Pan L, Liu J, Shi J (2014) Intranuclear photosensitizer delivery and photosensitization for enhanced photodynamic therapy with ultralow irradiance. Adv Funct Mater 24(46):7318–7327. doi: 10.1002/adfm.20140225510.1002/adfm.201402255 ↗
50. Brevet D, Gary-Bobo M, Raehm L, Richeter S, Hocine O, Amro K, Loock B, Couleaud P, Frochot C, Morere A, Maillard P, Garcia M, Durand JO (2009) Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem Commun 12:1475–1477. doi: 10.1039/b900427k10.1039/b900427k ↗
51. Warther D, Jimenez CM, Raehm L, Gerardin C, Durand J-O, Morere A, El Cheikh K, Gallud A, Gary-Bobo M, Maynadier M, Garcia M (2014) Small sized mesoporous silica nanoparticles functionalized with mannose for retinoblastoma cell imaging. RSC Adv 4(70):37171–37179. doi: 10.1039/c4ra05310a10.1039/c4ra05310a ↗
52. Hocine O, Gary-Bobo M, Brevet D, Maynadier M, Fontanel S, Raehm L, Richeter S, Loock B, Couleaud P, Frochot C, Charnay C, Derrien G, Smaihi M, Sahmoune A, Morere A, Maillard P, Garcia M, Durand J-O (2010) Silicalites and mesoporous silica nanoparticles for photodynamic therapy. Int J Pharm 402(1–2):221–23010.1016/j.ijpharm.2010.10.004 ↗
53. De Rosa M, Crutchley RJ (2002) Photosensitized singlet oxygen and its applications. Coord Chem Rev 233–234:351–371. doi: 10.1016/S0010-8545(02)00034-610.1016/S0010-8545(02)00034-6 ↗